Biotech
A research team has developed a new type of RNA structure targeting tool to specifically recognise unusual four-strand RNA structures, which are associated with diseases such as cancer and neurological disorders. The findings could help develop new therapeutic tools for related treatments. The research was led by Dr Kwok Chun-kit, associate professor in the Department of [...]
Gene editing may be used to treat anxiety and alcohol use disorder in adults who were exposed to binge drinking in their adolescence, according to the results of an animal study published in the journal Science Advances. The study is issued by researchers from the University of Illinois Chicago who have been studying the effects [...]
Biopharmaceutical company ReViral Ltd has entered into a definitive agreement to be acquired by Pfizer for up to US$525 million in total deal value. Founded in 2011, ReViral discovers, develops and commercialises novel antiviral therapeutics that target respiratory syncytial virus (RSV). RSV is a respiratory pathogen which can lead to severe and life-threatening lower respiratory [...]
A biotech company working to eliminate the vaccine cold chain has revealed some promising results from its Tetanus-diphtheria (Td) research programme. Stablepharma has successfully demonstrated that its reformulated Td vaccine remains stable at 45°c for up to 10 months. Td-StablevaX-M is a pre-filled disposable syringe containing a dry, stabilised Td vaccine that is injected after [...]
Scientists have discovered a novel way of separating strong sperm cells from their impotent peers. By using an ingenious microchip method, researchers at Florida Atlantic University College of Engineering and Computer Science have developed a microfluidic chip for sperm sorting. The chip is fast, inexpensive, easy to operate and efficiently isolates healthy sperm directly from [...]
Health tech startup Sano Genetics has raised US$11M in a Series A funding to advance its software that links people with chronic and rare conditions with pharma and biotech firms. The firm, founded by three Cambridge University graduates, has developed a platform that connects patients living with conditions, such as long Covid, multiple sclerosis, Parkinson’s and Alzheimer’s, [...]
The life sciences sector’s failure to adequately provide ‘connected health’ products and services to patients will prove a boon to Big Tech, according to a new report. Capgemini’s research reveals that, despite high ambitions, only a few life sciences organisations have the digital, technical and collaborative abilities to realise the potential of connected health. And less [...]
A common food source has been converted into a biomanufacturing platform that enables mass production of biologic drugs for common diseases that currently lack effective treatments. Researchers at Lumen Bioscience have pioneered genetic engineering methods to highly express bioactive proteins in spirulina using large-scale cultivation and processing methods appropriate for biopharmaceutical manufacturing. A report on [...]
Therapeutic bacteria can now 'hide' from being hunted down by immune systems, thanks to pioneering work performed at Columbia University in the US. Researchers report that they have developed a 'cloaking' system that temporarily hides the beneficial bugs from immune systems, allowing them to more effectively deliver drugs to tumours and kill cancer cells in [...]
Spanish biotech KeyZell is aiming for €5m in funding to conduct a human clinical trial for its novel brain cancer treatment. Based on company founder Dr.Nabil Hajji's research on cellular apoptosis induced by cell receptor blockage, the start-up will also use the investment to improve its AI system to personalise treatment for each cancer patient. Collaborating [...]
